How to profit from September stock-market weakness
It's possible to exploit September's poor seasonal stock-market odds without going short the market. Instead, you can shift into industries and sectors that historically have done well in September.
It's possible to exploit September's poor seasonal stock-market odds without going short the market. Instead, you can shift into industries and sectors that historically have done well in September.
DENVER--(BUSINESS WIRE)--Royal Gold Presenting at the 2026 Jefferies Global Industials Conference.
CWCO, CRTO and RGLD have been added to the Zacks Rank #5 (Strong Sell) List on August 27th, 2026.
Shares of Royal Gold, Inc. (RGLD) up 1,191% since institutions first bought big in 2003.
Royal Gold (RGLD) is rated a Buy, driven by robust cash flow, rapid deleveraging, and a discounted valuation versus peers. RGLD's portfolio expansion, including Sandstorm Gold and the $1B Kansanshi stream, has boosted GEOs and positioned the company for strong organic growth. Operating cash flow hit record highs, debt is falling rapidly, and share buybacks plus dividend growth are underway, enhancing shareholder returns.
Ongoing AI data center construction should drive demand for silver and copper. Various macroeconomic factors suggest gold will once again head higher.
Bard Associates Inc. purchased a new stake in Royal Gold, Inc. (NASDAQ: RGLD) (TSE: RGL) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 13,916 shares of the basic materials company's stock, valued at approximately $2,778,000. Other institutional investors and hedge funds also recently
Allworth Financial LP acquired a new position in shares of Royal Gold, Inc. (NASDAQ: RGLD) (TSE: RGL) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,449 shares of the basic materials company's stock, valued at approximately $2,086,000. Several other large investors have also
BlackRock Inc. bought a new position in shares of Royal Gold, Inc. (NASDAQ: RGLD) (TSE: RGL) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,910,603 shares of the basic materials company's stock, valued at approximately $2,177,865,000. BlackRock Inc. owned
DENVER--(BUSINESS WIRE)--Royal Gold Announces Fourth Quarter Dividend.
Royal Gold, Inc. (RGLD) Presents at Virtual Non-Deal Roadshow Series Transcript
JPMorgan Chase believes gold will reach $5,000 an ounce by the fourth quarter of the year, before pushing even higher. Gold is often viewed as a hedge and diversification tool, and there are several ways to invest in it.
On August 07, 2026, Royal Gold Inc (RGLD) shares rose 5.4% today to a current price of $229.92, significantly up from its 52-week low of $162.02 and still below
Royal Gold posts higher Q2 revenues and record operating cash flow despite an earnings miss, driven by stronger metal prices and new asset contributions.
Royal Gold NASDAQ: RGLD reported sharply higher second-quarter 2026 revenue, earnings and operating cash flow, as contributions from acquisitions completed in 2025, higher metal prices and increased volumes expanded the scale of its portfolio.
Royal Gold, Inc. (RGLD) Q2 2026 Earnings Call Transcript
On August 05, 2026, Royal Gold Inc (RGLD) shares rose 4.4% to $215.09, showing a positive trend amidst a challenging year-to-date performance of -2.6%. The stoc
DENVER--(BUSINESS WIRE)--Royal Gold Reports Strong Second Quarter Financial Results Including Record Operating Cash Flow, Repurchase of Shares and Further Repayment of Debt.
Shares of Royal Gold, Inc. (NASDAQ: RGLD - Get Free Report) (TSE: RGL) have received a consensus rating of "Moderate Buy" from the thirteen brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and nine have assigned a buy
On July 30, 2026, Royal Gold Inc (RGLD) shares rose 3.9% to a current price of $203.04. This price is situated within a 52-week range of $150.99 to $306.25, ref